Cargando…
What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries
OBJECTIVE: Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their diabetes treatment than those on oral hypoglycaemic therapies or lifestyle advice only. Determinants of satisfaction in patients with T2DM on insulin therapy are not clearly known. The aim of this study...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541515/ https://www.ncbi.nlm.nih.gov/pubmed/28701411 http://dx.doi.org/10.1136/bmjopen-2017-016180 |
_version_ | 1783254823979712512 |
---|---|
author | Boels, Anne Meike Vos, Rimke C Hermans, Tom G T Zuithoff, Nicolaas P A Müller, Nicolle Khunti, Kamlesh Rutten, Guy E H M |
author_facet | Boels, Anne Meike Vos, Rimke C Hermans, Tom G T Zuithoff, Nicolaas P A Müller, Nicolle Khunti, Kamlesh Rutten, Guy E H M |
author_sort | Boels, Anne Meike |
collection | PubMed |
description | OBJECTIVE: Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their diabetes treatment than those on oral hypoglycaemic therapies or lifestyle advice only. Determinants of satisfaction in patients with T2DM on insulin therapy are not clearly known. The aim of this study was to determine the association of treatment satisfaction with demographic and clinical characteristics of patients with T2DM. DESIGN: For this study we used data from the GUIDANCE (Guideline Adherence to Enhance Care) study, a cross-sectional study among 7597 patients with T2DM patients from Belgium, France, Germany, Ireland, Italy, Sweden, the Netherlands and the UK. The majority of patients were recruited from primary care. Treatment satisfaction was assessed by the Diabetes Treatment Satisfaction Questionnaire (DTSQ, score 0–36; higher scores reflecting higher satisfaction). To determine which patient characteristics and laboratory values were independently associated with treatment satisfaction, a linear mixed model analysis was used. PARTICIPANTS: In total, 1984 patients on insulin were analysed; the number of included patients per country ranged from 166 (the Netherlands) to 384 (Italy). RESULTS: The mean DTSQ score was 28.50±7.52 and ranged from 25.93±6.57 (France) to 30.11±5.09 (the Netherlands). Higher DTSQ scores were associated with having received diabetes education (β 1.64, 95% CI 0.95 to 2.32), presence of macrovascular complications (β 0.76, 95% CI 0.21 to 1.31) and better health status (β 0.08 for every one unit increase on a 0–100 scale, 95% CI 0.07 to 0.10). Lower DTSQ scores were associated with more frequently perceived hyperglycaemia (β −0.32 for every 1 unit increase on a seven-point Likert scale, 95% CI −0.50 to −0.13), and higher glycated haemoglobin (β −0.52 for every percentage increase, 95% CI −0.75 to −0.29). CONCLUSIONS: A number of factors including diabetes education, perceived and actual hyperglycaemia and macrovascular complications are associated with treatment satisfaction. Self-management education programmes should incorporate these factors for ongoing support in patients with T2DM. |
format | Online Article Text |
id | pubmed-5541515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-55415152017-08-18 What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries Boels, Anne Meike Vos, Rimke C Hermans, Tom G T Zuithoff, Nicolaas P A Müller, Nicolle Khunti, Kamlesh Rutten, Guy E H M BMJ Open Diabetes and Endocrinology OBJECTIVE: Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their diabetes treatment than those on oral hypoglycaemic therapies or lifestyle advice only. Determinants of satisfaction in patients with T2DM on insulin therapy are not clearly known. The aim of this study was to determine the association of treatment satisfaction with demographic and clinical characteristics of patients with T2DM. DESIGN: For this study we used data from the GUIDANCE (Guideline Adherence to Enhance Care) study, a cross-sectional study among 7597 patients with T2DM patients from Belgium, France, Germany, Ireland, Italy, Sweden, the Netherlands and the UK. The majority of patients were recruited from primary care. Treatment satisfaction was assessed by the Diabetes Treatment Satisfaction Questionnaire (DTSQ, score 0–36; higher scores reflecting higher satisfaction). To determine which patient characteristics and laboratory values were independently associated with treatment satisfaction, a linear mixed model analysis was used. PARTICIPANTS: In total, 1984 patients on insulin were analysed; the number of included patients per country ranged from 166 (the Netherlands) to 384 (Italy). RESULTS: The mean DTSQ score was 28.50±7.52 and ranged from 25.93±6.57 (France) to 30.11±5.09 (the Netherlands). Higher DTSQ scores were associated with having received diabetes education (β 1.64, 95% CI 0.95 to 2.32), presence of macrovascular complications (β 0.76, 95% CI 0.21 to 1.31) and better health status (β 0.08 for every one unit increase on a 0–100 scale, 95% CI 0.07 to 0.10). Lower DTSQ scores were associated with more frequently perceived hyperglycaemia (β −0.32 for every 1 unit increase on a seven-point Likert scale, 95% CI −0.50 to −0.13), and higher glycated haemoglobin (β −0.52 for every percentage increase, 95% CI −0.75 to −0.29). CONCLUSIONS: A number of factors including diabetes education, perceived and actual hyperglycaemia and macrovascular complications are associated with treatment satisfaction. Self-management education programmes should incorporate these factors for ongoing support in patients with T2DM. BMJ Publishing Group 2017-07-11 /pmc/articles/PMC5541515/ /pubmed/28701411 http://dx.doi.org/10.1136/bmjopen-2017-016180 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Diabetes and Endocrinology Boels, Anne Meike Vos, Rimke C Hermans, Tom G T Zuithoff, Nicolaas P A Müller, Nicolle Khunti, Kamlesh Rutten, Guy E H M What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries |
title | What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries |
title_full | What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries |
title_fullStr | What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries |
title_full_unstemmed | What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries |
title_short | What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries |
title_sort | what determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? an observational study in eight european countries |
topic | Diabetes and Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541515/ https://www.ncbi.nlm.nih.gov/pubmed/28701411 http://dx.doi.org/10.1136/bmjopen-2017-016180 |
work_keys_str_mv | AT boelsannemeike whatdeterminestreatmentsatisfactionofpatientswithtype2diabetesoninsulintherapyanobservationalstudyineighteuropeancountries AT vosrimkec whatdeterminestreatmentsatisfactionofpatientswithtype2diabetesoninsulintherapyanobservationalstudyineighteuropeancountries AT hermanstomgt whatdeterminestreatmentsatisfactionofpatientswithtype2diabetesoninsulintherapyanobservationalstudyineighteuropeancountries AT zuithoffnicolaaspa whatdeterminestreatmentsatisfactionofpatientswithtype2diabetesoninsulintherapyanobservationalstudyineighteuropeancountries AT mullernicolle whatdeterminestreatmentsatisfactionofpatientswithtype2diabetesoninsulintherapyanobservationalstudyineighteuropeancountries AT khuntikamlesh whatdeterminestreatmentsatisfactionofpatientswithtype2diabetesoninsulintherapyanobservationalstudyineighteuropeancountries AT ruttenguyehm whatdeterminestreatmentsatisfactionofpatientswithtype2diabetesoninsulintherapyanobservationalstudyineighteuropeancountries |